Risk loci for coronary artery calcification replicated at 9p21 and 6q24 in the Heinz Nixdorf Recall Study
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Risk loci for coronary artery calcification replicated at 9p21 and 6q24 in the Heinz Nixdorf Recall Study
Authors
Keywords
Coronary heart disease, Coronary artery calcification, Cohort study, Polymorphism, Metabochip
Journal
BMC Medical Genetics
Volume 14, Issue 1, Pages -
Publisher
Springer Nature
Online
2013-02-09
DOI
10.1186/1471-2350-14-23
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Sex Differences in Subclinical Atherosclerosis by Race/Ethnicity in the Multi-Ethnic Study of Atherosclerosis
- (2011) C. Kim et al. AMERICAN JOURNAL OF EPIDEMIOLOGY
- Genome-Wide Association Study for Coronary Artery Calcification With Follow-Up in Myocardial Infarction
- (2011) Christopher J. O'Donnell et al. CIRCULATION
- A Genome-Wide Association Study Identifies LIPA as a Susceptibility Gene for Coronary Artery Disease
- (2011) Philipp S. Wild et al. Circulation-Cardiovascular Genetics
- 9p21 DNA variants associated with coronary artery disease impair interferon-γ signalling response
- (2011) Olivier Harismendy et al. NATURE
- Large-scale association analysis identifies 13 new susceptibility loci for coronary artery disease
- (2011) Heribert Schunkert et al. NATURE GENETICS
- A genome-wide association study in Europeans and South Asians identifies five new loci for coronary artery disease
- (2011) John F Peden et al. NATURE GENETICS
- Coronary Artery Calcification and Its Relationship to Validated Genetic Variants for Diabetes Mellitus Assessed in the Heinz Nixdorf Recall Cohort
- (2010) Sonali Pechlivanis et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Genome-wide association study identifies a new locus for coronary artery disease on chromosome 10p11.23
- (2010) J. Erdmann et al. EUROPEAN HEART JOURNAL
- Coronary Risk Stratification, Discrimination, and Reclassification Improvement Based on Quantification of Subclinical Coronary Atherosclerosis
- (2010) Raimund Erbel et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Targeted deletion of the 9p21 non-coding coronary artery disease risk interval in mice
- (2010) Axel Visel et al. NATURE
- Common variants in KCNN3 are associated with lone atrial fibrillation
- (2010) Patrick T Ellinor et al. NATURE GENETICS
- A Common Variant at 9p21 Is Associated With Sudden and Arrhythmic Cardiac Death
- (2009) Christopher Newton-Cheh et al. CIRCULATION
- New susceptibility locus for coronary artery disease on chromosome 3q22.3
- (2009) Jeanette Erdmann et al. NATURE GENETICS
- Genome-wide haplotype association study identifies the SLC22A3-LPAL2-LPA gene cluster as a risk locus for coronary artery disease
- (2009) David-Alexandre Trégouët et al. NATURE GENETICS
- Genome-wide association of early-onset myocardial infarction with single nucleotide polymorphisms and copy number variants
- (2009) Sekar Kathiresan et al. NATURE GENETICS
- Association of impaired fasting glucose and coronary artery calcification as a marker of subclinical atherosclerosis in a population-based cohort—results of the Heinz Nixdorf Recall Study
- (2008) S. Moebus et al. DIABETOLOGIA
- Signs of subclinical coronary atherosclerosis in relation to risk factor distribution in the Multi-Ethnic Study of Atherosclerosis (MESA) and the Heinz Nixdorf Recall Study (HNR)
- (2008) R. Erbel et al. EUROPEAN HEART JOURNAL
- The same sequence variant on 9p21 associates with myocardial infarction, abdominal aortic aneurysm and intracranial aneurysm
- (2008) Anna Helgadottir et al. NATURE GENETICS
- Subclinical coronary atherosclerosis and resting ECG abnormalities in an unselected general population
- (2007) Stefan Möhlenkamp et al. ATHEROSCLEROSIS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started